Key markers include GLP1R rs6923761 (GLP-1 receptor sensitivity), GIPR rs1800437 (glucose-dependent insulinotropic peptide response), FTO rs9939609 (fat mass and obesity), and MC4R rs17782313 (melanocortin pathway function)
Cancer Hcy competes with SAMe, affecting DNA methylation and harming brain function, which can lead to mental health and nervous system disorders
If you buy coverage through the marketplace, then it's probably the case that your health plan is not going to cover these drugs, said Cynthia Cox at the health policy nonprofit KFF
GLP-1 receptor agonists like semaglutide act on brain centers that control hunger, satiety, and food preferencenot just appetite suppression
This reader wants to know why the FDA permits physicians to prescribe a diabetes drug for weight loss, especially when there is a shortage of both Ozempic and Wegovy
In addition, long-term cardiovascular, maintenance, and safety outcomes remain under study